MOH — authorised 24 November 2015
- Marketing authorisation holder: ELI LILLY CO
- Status: likely_approved
MOH authorised Portrazza on 24 November 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 24 November 2015.
ELI LILLY CO holds the UAE marketing authorisation.